mRNA vaccine technology moves to flu: Moderna says trial has begun
Moderna has given out the first doses of an mRNA-based influenza vaccine to participants in an early-phase clinical trial, the company announced Wednesday. Moderna ultimately plans to test the vaccine on about 180 people in the Phase 1/2 randomized, stratified, observer-blind trial. The trial will look at safety, different doses, and immune responses.
Continue Reading https://arstechnica.com
Join the Discussion